139 related articles for article (PubMed ID: 38868238)
1. Pathogenesis of Medication-Related Osteonecrosis of the Jaw: Odontogenic Infection-Preceding Type and Osteonecrosis-Preceding Type.
Sakamoto Y; Sawada S; Kojima Y
Cureus; 2024 May; 16(5):e60223. PubMed ID: 38868238
[TBL] [Abstract][Full Text] [Related]
2. Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: a retrospective and observational study.
Sakamoto Y; Sawada S; Kojima Y
Sci Rep; 2023 Aug; 13(1):12890. PubMed ID: 37558709
[TBL] [Abstract][Full Text] [Related]
3. Medication-related osteonecrosis of the lower jaw without osteolysis on computed tomography images.
Kojima Y; Sawada S; Sakamoto Y
J Bone Miner Metab; 2024 Jan; 42(1):27-36. PubMed ID: 38194089
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for dental findings of the development of medication-related osteonecrosis of the jaw: Investigation of 3734 teeth in cancer patients receiving high dose antiresorptive agents.
Otsuru M; Fujiki Y; Soutome S; Nakamura N; Miyoshi T; Naruse T; Ohnuma M; Hotokezaka Y; Rokutanda S; Umeda M
J Dent Sci; 2024 Jan; 19(1):203-210. PubMed ID: 38303840
[TBL] [Abstract][Full Text] [Related]
5. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
6. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O; Peter JU
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012432. PubMed ID: 35866376
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional clinical assessment for MRONJ risk in oncologic patients following tooth extractions.
Moreno Rabie C; Cavalcante Fontenele R; Oliveira Santos N; Nogueira Reis F; Van den Wyngaert T; Jacobs R
Dentomaxillofac Radiol; 2023 Nov; 52(8):20230238. PubMed ID: 37874081
[TBL] [Abstract][Full Text] [Related]
8. How does the clinical and tomographic appearance of MRONJ influences its treatment prognosis?
Moreno Rabie C; García-Larraín S; Contreras Diez de Medina D; Cabello-Salazar I; Fontenele RC; Van den Wyngaert T; Jacobs R
Dentomaxillofac Radiol; 2023 Nov; 52(8):20230304. PubMed ID: 37870051
[TBL] [Abstract][Full Text] [Related]
9. Radiographic Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) With Different Primary Cancers and Medication Therapies.
Muttanahally KS; Tadinada A
Cureus; 2023 Aug; 15(8):e42830. PubMed ID: 37664344
[TBL] [Abstract][Full Text] [Related]
10. Can dental panoramic radiographic findings serve as indicators for the development of medication-related osteonecrosis of the jaw?
Klingelhöffer C; Klingelhöffer M; Müller S; Ettl T; Wahlmann U
Dentomaxillofac Radiol; 2016; 45(5):20160065. PubMed ID: 27213837
[TBL] [Abstract][Full Text] [Related]
11. Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab.
Wick A; Bankosegger P; Otto S; Hohlweg-Majert B; Steiner T; Probst F; Ristow O; Pautke C
Clin Oral Investig; 2022 Mar; 26(3):2839-2852. PubMed ID: 34812959
[TBL] [Abstract][Full Text] [Related]
12. The progress of medication-related osteonecrosis of the jaw with conservative initial treatment: A 12-year retrospective study of 129 patients.
Kaibuchi N; Hoshi K; Yamazaki A; Miyamoto-Sangu N; Akagi Y; Okamoto T
Bone Rep; 2021 Jun; 14():101072. PubMed ID: 33997149
[TBL] [Abstract][Full Text] [Related]
13. Relationship between Drug Holidays of Antiresorptive Agents and Surgical Outcomes in Cancer Patients with Medication-Related Osteonecrosis of the Jaw.
Otsuru M; Soutome S; Omori K; Suyama K; Morishita K; Hayashida S; Murata M; Takagi Y; Sasaki M; Sumi M; Kojima Y; Sawada S; Sakamoto Y; Umeda M
Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457491
[TBL] [Abstract][Full Text] [Related]
14. Contribution of Antiangiogenic Agents to the Risk of Medication-related Osteonecrosis of the Jaw in Combination with Antiresorptive Agents: Preliminary Results in a Comparative Prospective Report of 59 Oncologic Cases.
Yanni A; Bouland C; Monteiro R; Rodriguez A; Loeb I; Javadian R; Dequanter D
J Int Soc Prev Community Dent; 2022; 12(5):564-570. PubMed ID: 36532328
[TBL] [Abstract][Full Text] [Related]
15. Periosteal reaction of medication-related osteonecrosis of the jaw (MRONJ): clinical significance and changes during conservative therapy.
Soutome S; Otsuru M; Hayashida S; Yanamoto S; Sasaki M; Takagi Y; Sumi M; Kojima Y; Sawada S; Iwai H; Umeda M; Saito T
Support Care Cancer; 2021 Nov; 29(11):6361-6368. PubMed ID: 33884506
[TBL] [Abstract][Full Text] [Related]
16. Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication).
Baba A; Ojiri H; Goto TK; Ikeda K; Yamauchi H; Ogino N; Mogami T
Jpn Dent Sci Rev; 2019 Nov; 55(1):58-64. PubMed ID: 30815046
[TBL] [Abstract][Full Text] [Related]
17. Medication-Related Osteonecrosis of the Jaws in the Pediatric Population.
Neal TW; Schlieve T
J Oral Maxillofac Surg; 2022 Oct; 80(10):1686-1690. PubMed ID: 35931181
[TBL] [Abstract][Full Text] [Related]
18. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of mandibular bone marrow using computed tomography texture analysis for detect stage 0 medication-related osteonecrosis of the jaw.
Ito K; Muraoka H; Hirahara N; Sawada E; Hirohata S; Otsuka K; Okada S; Kaneda T
Eur J Radiol; 2021 Dec; 145():110030. PubMed ID: 34798536
[TBL] [Abstract][Full Text] [Related]
20. Medication-related osteonecrosis of the upper jaw involving the zygomatic bone: A case report.
Otsuru M; Soutome S; Hayashida S; Morishita K; Yanamoto S; Umeda M
Int J Surg Case Rep; 2023 Mar; 104():107932. PubMed ID: 36801766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
